Connect your AI

Establishment Labs ESTA Business Combination, Contingent Consideration, Liability

Business Combination, Contingent Consideration, Liability at other companies

Globus MedicalGMED

——

Boston ScientificBSX

——

Other financials

Income statement

Revenue$59.9M+44.7%

Gross profit$42.3M+52.2%

Operating income-$6.5M+61.6%

Net income-$13.4M+35.4%

EPS (diluted)-$0.45+35.7%

Balance sheet

Cash & equivalents$68.1M-1.6%

Total debt$252.7M+12.0%

Total equity$14.8M-61.7%

Total assets$351.0M+5.3%

Cash flow

Operating cash flow-$4.3M+79.2%

CapEx$1.9M+146%

Free cash flow-$6.2M+71.3%

Valuation

Market cap$2.56B+41.4%

Enterprise value$2.75B+38.7%

P/S11.2×+0.5×

Profitability

Gross margin70.1%+3.7pp

Operating margin-12.4%-4.8pp

Net margin-19.1%-7.4pp

FCF margin-18.1%-6.6pp

Returns & leverage

Return on equity-164%-17.8pp

Debt / equity17.1×+11.2×

Current ratio3×-0.4×

Where this comes from

Reported directly by Establishment Labs in its filing.

Tagged under the XBRL concept us-gaap:BusinessCombinationContingentConsiderationLiability.

The official record: Establishment Labs’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Establishment Labs's business combination, contingent consideration, liability.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Establishment Labs's business combination, contingent consideration, liability?: Establishment Labs (ESTA) reported business combination, contingent consideration, liability of $4.4M in Q1 2026.
How has Establishment Labs's business combination, contingent consideration, liability changed year-over-year?: Establishment Labs's business combination, contingent consideration, liability increased by 2317.6% year-over-year, from $182K to $4.4M.